title: Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins.
abstract: Cytolytic pore-forming toxins are important for the virulence of many disease-causing bacteria. How target cells molecularly respond to these toxins and whether or not they can mount a defense are poorly understood. By using microarrays, we demonstrate that the nematode Caenorhabditis elegans responds robustly to Cry5B, a member of the pore-forming Crystal toxin family made by Bacillus thuringiensis. This genomic response is distinct from that seen with a different stressor, the heavy metal cadmium. A p38 mitogen-activated protein kinase (MAPK) kinase and a c-Jun N-terminal-like MAPK are both transcriptionally up-regulated by Cry5B. Moreover, both MAPK pathways are functionally important because elimination of either leads to animals that are (i) hypersensitive to a low, chronic dose of toxin and (ii) hypersensitive to a high, brief dose of toxin such that the animal might naturally encounter in the wild. These results extend to mammalian cells because inhibition of p38 results in the hypersensitivity of baby hamster kidney cells to aerolysin, a pore-forming toxin that targets humans. Furthermore, we identify two downstream transcriptional targets of the p38 MAPK pathway, ttm-1 and ttm-2, that are required for defense against Cry5B. Our data demonstrate that cells defend against pore-forming toxins by means of conserved MAPK pathways.
authors.affiliation: Section of Cell and Developmental Biology, University of California at San Diego, La Jolla, 92093, USA.
authors.forename: Danielle L
authors.initials: DL
authors.lastname: Huffman
authors.forename: Laurence
authors.initials: L
authors.lastname: Abrami
authors.forename: Roman
authors.initials: R
authors.lastname: Sasik
authors.forename: Jacques
authors.initials: J
authors.lastname: Corbeil
authors.forename: F Gisou
authors.initials: FG
authors.lastname: van der Goot
authors.forename: Raffi V
authors.initials: RV
authors.lastname: Aroian
mesh_terms: D000818:Animals; D001413:Bacillus thuringiensis; D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins / Q000633:toxicity*; D001427:Bacterial Toxins / Q000633:toxicity*; D017173:Caenorhabditis elegans / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D029742:Caenorhabditis elegans Proteins / Q000378:metabolism; D004731:Endotoxins / Q000633:toxicity*; D006460:Hemolysin Proteins; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology*; D020928:Mitogen-Activated Protein Kinases / Q000187:drug effects / Q000378:metabolism*; D020411:Oligonucleotide Array Sequence Analysis; D018510:RNA, Helminth / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D048051:p38 Mitogen-Activated Protein Kinases
chemical_list: D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D029742:Caenorhabditis elegans Proteins; D004731:Endotoxins; D006460:Hemolysin Proteins; D018510:RNA, Helminth; D034741:RNA, Small Interfering; C030956:insecticidal crystal protein, Bacillus Thuringiensis; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases